+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Azithromycin Market by Product Type, Distribution Channel, End User, Application, Therapeutic Area - Global Forecast 2025-2030- Product Image
Azithromycin Market by Product Type, Distribution Channel, End User, Application, Therapeutic Area - Global Forecast 2025-2030- Product Image
Sale

Azithromycin Market by Product Type, Distribution Channel, End User, Application, Therapeutic Area - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 193 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6013823
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Azithromycin Market grew from USD 7.01 billion in 2023 to USD 7.40 billion in 2024. It is expected to continue growing at a CAGR of 5.68%, reaching USD 10.33 billion by 2030.

Azithromycin, a broad-spectrum antibiotic belonging to the macrolide class, serves as a critical therapeutic agent in combating bacterial infections such as respiratory tract infections, skin infections, and sexually transmitted diseases. Its necessity in the healthcare sector stems from its efficacy against a wide range of bacterial pathogens, its user-friendly dosage regimen, and fewer drug interactions compared to other antibiotics. The primary application of Azithromycin spans across hospitals, clinics, and outpatient facilities, with the pharmaceuticals and hospitals being significant end-users. The azithromycin market is propelled by factors such as the rising prevalence of infectious diseases, global demand for effective antibacterial treatments, and its role in treating COVID-19-related complications, although the latter has seen fluctuating use based on evolving guidelines. Latest growth opportunities include increasing use in emerging markets, strategic collaborations among pharmaceutical companies for drug development, and expanding the scope of azithromycin to novel therapeutic areas through advanced research. However, the market faces challenges such as antibiotic resistance, regulatory hurdles, and potential side effects, which can hinder growth. Innovation and research efforts are particularly promising in the development of combination therapies to counter antibiotic resistance, improved formulations for specific population needs, and innovations in drug delivery systems to enhance efficacy. The market's growth is influenced by government policies on antibiotic usage, awareness initiatives on antimicrobial stewardship, and ongoing investments in healthcare infrastructure. Despite facing challenges, the dynamic nature of the azithromycin market provides ample opportunities for strategic growth through adaptation, diversification into related healthcare sectors, and emphasis on R&D. Industry players should focus on enhancing accessibility in developing countries and exploring azithromycin's potential in non-traditional therapeutic areas to secure a competitive edge.

Understanding Market Dynamics in the Azithromycin Market

The Azithromycin Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing occurrence of bacterial infections globally
    • Growing trend of combination therapies involving azithromycin for more effective infection management
    • Development of generic azithromycin formulations leading to cost-effective treatment options
  • Market Restraints
    • Stringent regulatory requirements for azithromycin production
  • Market Opportunities
    • Surge in investments in pharmaceutical research and development for innovative antibiotic solutions
    • Expansion of azithromycin applications in treating sexually transmitted infections and other conditions
  • Market Challenges
    • Prevalence of side effects associated with azithromycin

Exploring Porter’s Five Forces for the Azithromycin Market

Porter’s Five Forces framework further strengthens the insights of the Azithromycin Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Azithromycin Market

External macro-environmental factors deeply influence the performance of the Azithromycin Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Azithromycin Market

The Azithromycin Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Azithromycin Market

The Azithromycin Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Azithromycin Market

The Azithromycin Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Azithromycin Market, highlighting leading vendors and their innovative profiles. These include AbbVie, Amgen, AstraZeneca, Aurobindo Pharma, Bayer, Bristol-Myers Squibb, Cipla, Dr. Reddy's Laboratories, Eli Lilly and Company, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Mylan, Novartis, Pfizer, Sandoz, Sanofi, Sun Pharmaceutical, and Teva Pharmaceuticals.

Market Segmentation & Coverage

This research report categorizes the Azithromycin Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product Type
    • Injection
    • Suspension
    • Tablet
      • Extended-Release
      • Immediate-Release
  • Distribution Channel
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
  • End User
    • Clinics
    • Home Care Settings
    • Hospitals
  • Application
    • Bacterial Infections
      • Ear Infections
      • Eye Infections
      • Respiratory Infections
      • Skin Infections
    • Sexually Transmitted Diseases
      • Chlamydia
      • Gonorrhea
  • Therapeutic Area
    • Dermatology
    • Ophthalmology
    • Otology
    • Respiratory
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing occurrence of bacterial infections globally
5.1.1.2. Growing trend of combination therapies involving azithromycin for more effective infection management
5.1.1.3. Development of generic azithromycin formulations leading to cost-effective treatment options
5.1.2. Restraints
5.1.2.1. Stringent regulatory requirements for azithromycin production
5.1.3. Opportunities
5.1.3.1. Surge in investments in pharmaceutical research and development for innovative antibiotic solutions
5.1.3.2. Expansion of azithromycin applications in treating sexually transmitted infections and other conditions
5.1.4. Challenges
5.1.4.1. Prevalence of side effects associated with azithromycin
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Azithromycin Market, by Product Type
6.1. Introduction
6.2. Injection
6.3. Suspension
6.4. Tablet
6.4.1. Extended-Release
6.4.2. Immediate-Release
7. Azithromycin Market, by Distribution Channel
7.1. Introduction
7.2. Hospital Pharmacies
7.3. Online Pharmacies
7.4. Retail Pharmacies
8. Azithromycin Market, by End User
8.1. Introduction
8.2. Clinics
8.3. Home Care Settings
8.4. Hospitals
9. Azithromycin Market, by Application
9.1. Introduction
9.2. Bacterial Infections
9.2.1. Ear Infections
9.2.2. Eye Infections
9.2.3. Respiratory Infections
9.2.4. Skin Infections
9.3. Sexually Transmitted Diseases
9.3.1. Chlamydia
9.3.2. Gonorrhea
10. Azithromycin Market, by Therapeutic Area
10.1. Introduction
10.2. Dermatology
10.3. Ophthalmology
10.4. Otology
10.5. Respiratory
11. Americas Azithromycin Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Azithromycin Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Azithromycin Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. AZITHROMYCIN MARKET RESEARCH PROCESS
FIGURE 2. AZITHROMYCIN MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL AZITHROMYCIN MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL AZITHROMYCIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL AZITHROMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 9. GLOBAL AZITHROMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL AZITHROMYCIN MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL AZITHROMYCIN MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL AZITHROMYCIN MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 13. GLOBAL AZITHROMYCIN MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL AZITHROMYCIN MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
FIGURE 15. GLOBAL AZITHROMYCIN MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. AMERICAS AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES AZITHROMYCIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 19. UNITED STATES AZITHROMYCIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. AZITHROMYCIN MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 25. AZITHROMYCIN MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. AZITHROMYCIN MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL AZITHROMYCIN MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL AZITHROMYCIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. AZITHROMYCIN MARKET DYNAMICS
TABLE 7. GLOBAL AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL AZITHROMYCIN MARKET SIZE, BY INJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL AZITHROMYCIN MARKET SIZE, BY SUSPENSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL AZITHROMYCIN MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL AZITHROMYCIN MARKET SIZE, BY EXTENDED-RELEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL AZITHROMYCIN MARKET SIZE, BY IMMEDIATE-RELEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL AZITHROMYCIN MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL AZITHROMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL AZITHROMYCIN MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL AZITHROMYCIN MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL AZITHROMYCIN MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL AZITHROMYCIN MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL AZITHROMYCIN MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL AZITHROMYCIN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL AZITHROMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL AZITHROMYCIN MARKET SIZE, BY BACTERIAL INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL AZITHROMYCIN MARKET SIZE, BY EAR INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL AZITHROMYCIN MARKET SIZE, BY EYE INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL AZITHROMYCIN MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL AZITHROMYCIN MARKET SIZE, BY CHLAMYDIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL AZITHROMYCIN MARKET SIZE, BY GONORRHEA, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL AZITHROMYCIN MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL AZITHROMYCIN MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL AZITHROMYCIN MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL AZITHROMYCIN MARKET SIZE, BY OTOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL AZITHROMYCIN MARKET SIZE, BY RESPIRATORY, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS AZITHROMYCIN MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS AZITHROMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS AZITHROMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS AZITHROMYCIN MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS AZITHROMYCIN MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA AZITHROMYCIN MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA AZITHROMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA AZITHROMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA AZITHROMYCIN MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA AZITHROMYCIN MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL AZITHROMYCIN MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL AZITHROMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL AZITHROMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL AZITHROMYCIN MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL AZITHROMYCIN MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 63. CANADA AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 64. CANADA AZITHROMYCIN MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 65. CANADA AZITHROMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 66. CANADA AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 67. CANADA AZITHROMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. CANADA AZITHROMYCIN MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 69. CANADA AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, 2018-2030 (USD MILLION)
TABLE 70. CANADA AZITHROMYCIN MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 71. MEXICO AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 72. MEXICO AZITHROMYCIN MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 73. MEXICO AZITHROMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. MEXICO AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. MEXICO AZITHROMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. MEXICO AZITHROMYCIN MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 77. MEXICO AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, 2018-2030 (USD MILLION)
TABLE 78. MEXICO AZITHROMYCIN MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES AZITHROMYCIN MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES AZITHROMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES AZITHROMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES AZITHROMYCIN MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES AZITHROMYCIN MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES AZITHROMYCIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 88. ASIA-PACIFIC AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 89. ASIA-PACIFIC AZITHROMYCIN MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 90. ASIA-PACIFIC AZITHROMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. ASIA-PACIFIC AZITHROMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC AZITHROMYCIN MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 94. ASIA-PACIFIC AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, 2018-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC AZITHROMYCIN MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 96. ASIA-PACIFIC AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 97. AUSTRALIA AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 98. AUSTRALIA AZITHROMYCIN MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 99. AUSTRALIA AZITHROMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 100. AUSTRALIA AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. AUSTRALIA AZITHROMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. AUSTRALIA AZITHROMYCIN MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 103. AUSTRALIA AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, 2018-2030 (USD MILLION)
TABLE 104. AUSTRALIA AZITHROMYCIN MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 105. CHINA AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 106. CHINA AZITHROMYCIN MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 107. CHINA AZITHROMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. CHINA AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. CHINA AZITHROMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. CHINA AZITHROMYCIN MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 111. CHINA AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, 2018-2030 (USD MILLION)
TABLE 112. CHINA AZITHROMYCIN MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 113. INDIA AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 114. INDIA AZITHROMYCIN MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 115. INDIA AZITHROMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 116. INDIA AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. INDIA AZITHROMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. INDIA AZITHROMYCIN MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 119. INDIA AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, 2018-2030 (USD MILLION)
TABLE 120. INDIA AZITHROMYCIN MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 121. INDONESIA AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 122. INDONESIA AZITHROMYCIN MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 123. INDONESIA AZITHROMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 124. INDONESIA AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. INDONESIA AZITHROMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. INDONESIA AZITHROMYCIN MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 127. INDONESIA AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, 2018-2030 (USD MILLION)
TABLE 128. INDONESIA AZITHROMYCIN MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 129. JAPAN AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 130. JAPAN AZITHROMYCIN MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 131. JAPAN AZITHROMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. JAPAN AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. JAPAN AZITHROMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. JAPAN AZITHROMYCIN MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 135. JAPAN AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, 2018-2030 (USD MILLION)
TABLE 136. JAPAN AZITHROMYCIN MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 137. MALAYSIA AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 138. MALAYSIA AZITHROMYCIN MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 139. MALAYSIA AZITHROMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 140. MALAYSIA AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. MALAYSIA AZITHROMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. MALAYSIA AZITHROMYCIN MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 143. MALAYSIA AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, 2018-2030 (USD MILLION)
TABLE 144. MALAYSIA AZITHROMYCIN MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 145. PHILIPPINES AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 146. PHILIPPINES AZITHROMYCIN MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 147. PHILIPPINES AZITHROMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 148. PHILIPPINES AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. PHILIPPINES AZITHROMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. PHILIPPINES AZITHROMYCIN MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 151. PHILIPPINES AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, 2018-2030 (USD MILLION)
TABLE 152. PHILIPPINES AZITHROMYCIN MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 153. SINGAPORE AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 154. SINGAPORE AZITHROMYCIN MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 155. SINGAPORE AZITHROMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 156. SINGAPORE AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. SINGAPORE AZITHROMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. SINGAPORE AZITHROMYCIN MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 159. SINGAPORE AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, 2018-2030 (USD MILLION)
TABLE 160. SINGAPORE AZITHROMYCIN MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 161. SOUTH KOREA AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 162. SOUTH KOREA AZITHROMYCIN MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 163. SOUTH KOREA AZITHROMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 164. SOUTH KOREA AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. SOUTH KOREA AZITHROMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. SOUTH KOREA AZITHROMYCIN MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 167. SOUTH KOREA AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, 2018-2030 (USD MILLION)
TABLE 168. SOUTH KOREA AZITHROMYCIN MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 169. TAIWAN AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 170. TAIWAN AZITHROMYCIN MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 171. TAIWAN AZITHROMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 172. TAIWAN AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. TAIWAN AZITHROMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. TAIWAN AZITHROMYCIN MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 175. TAIWAN AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, 2018-2030 (USD MILLION)
TABLE 176. TAIWAN AZITHROMYCIN MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 177. THAILAND AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 178. THAILAND AZITHROMYCIN MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 179. THAILAND AZITHROMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. THAILAND AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. THAILAND AZITHROMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. THAILAND AZITHROMYCIN MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 183. THAILAND AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, 2018-2030 (USD MILLION)
TABLE 184. THAILAND AZITHROMYCIN MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 185. VIETNAM AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 186. VIETNAM AZITHROMYCIN MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 187. VIETNAM AZITHROMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 188. VIETNAM AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. VIETNAM AZITHROMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. VIETNAM AZITHROMYCIN MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 191. VIETNAM AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, 2018-2030 (USD MILLION)
TABLE 192. VIETNAM AZITHROMYCIN MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, 2018-2030 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 202. DENMARK AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 203. DENMARK AZITHROMYCIN MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 204. DENMARK AZITHROMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 205. DENMARK AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 206. DENMARK AZITHROMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 207. DENMARK AZITHROMYCIN MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 208. DENMARK AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, 2018-2030 (USD MILLION)
TABLE 209. DENMARK AZITHROMYCIN MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 210. EGYPT AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 211. EGYPT AZITHROMYCIN MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 212. EGYPT AZITHROMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 213. EGYPT AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 214. EGYPT AZITHROMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. EGYPT AZITHROMYCIN MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 216. EGYPT AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, 2018-2030 (USD MILLION)
TABLE 217. EGYPT AZITHROMYCIN MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 218. FINLAND AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 219. FINLAND AZITHROMYCIN MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 220. FINLAND AZITHROMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 221. FINLAND AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. FINLAND AZITHROMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. FINLAND AZITHROMYCIN MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 224. FINLAND AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, 2018-2030 (USD MILLION)
TABLE 225. FINLAND AZITHROMYCIN MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 226. FRANCE AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 227. FRANCE AZITHROMYCIN MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 228. FRANCE AZITHROMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 229. FRANCE AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. FRANCE AZITHROMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. FRANCE AZITHROMYCIN MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 232. FRANCE AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, 2018-2030 (USD MILLION)
TABLE 233. FRANCE AZITHROMYCIN MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 234. GERMANY AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 235. GERMANY AZITHROMYCIN MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 236. GERMANY AZITHROMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 237. GERMANY AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 238. GERMANY AZITHROMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 239. GERMANY AZITHROMYCIN MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 240. GERMANY AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, 2018-2030 (USD MILLION)
TABLE 241. GERMANY AZITHROMYCIN MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 242. ISRAEL AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 243. ISRAEL AZITHROMYCIN MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 244. ISRAEL AZITHROMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 245. ISRAEL AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. ISRAEL AZITHROMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 247. ISRAEL AZITHROMYCIN MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 248. ISRAEL AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, 2018-2030 (USD MILLION)
TABLE 249. ISRAEL AZITHROMYCIN MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 250. ITALY AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 251. ITALY AZITHROMYCIN MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 252. ITALY AZITHROMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 253. ITALY AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 254. ITALY AZITHROMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 255. ITALY AZITHROMYCIN MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 256. ITALY AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, 2018-2030 (USD MILLION)
TABLE 257. ITALY AZITHROMYCIN MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 258. NETHERLANDS AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 259. NETHERLANDS AZITHROMYCIN MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 260. NETHERLANDS AZITHROMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 261. NETHERLANDS AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. NETHERLANDS AZITHROMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 263. NETHERLANDS AZITHROMYCIN MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 264. NETHERLANDS AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, 2018-2030 (USD MILLION)
TABLE 265. NETHERLANDS AZITHROMYCIN MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 266. NIGERIA AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 267. NIGERIA AZITHROMYCIN MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 268. NIGERIA AZITHROMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 269. NIGERIA AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 270. NIGERIA AZITHROMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 271. NIGERIA AZITHROMYCIN MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 272. NIGERIA AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, 2018-2030 (USD MILLION)
TABLE 273. NIGERIA AZITHROMYCIN MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 274. NORWAY AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 275. NORWAY AZITHROMYCIN MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 276. NORWAY AZITHROMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 277. NORWAY AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 278. NORWAY AZITHROMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 279. NORWAY AZITHROMYCIN MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 280. NORWAY AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, 2018-2030 (USD MILLION)
TABLE 281. NORWAY AZITHROMYCIN MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 282. POLAND AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 283. POLAND AZITHROMYCIN MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 284. POLAND AZITHROMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 285. POLAND AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 286. POLAND AZITHROMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 287. POLAND AZITHROMYCIN MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 288. POLAND AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, 2018-2030 (USD MILLION)
TABLE 289. POLAND AZITHROMYCIN MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 290. QATAR AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 291. QATAR AZITHROMYCIN MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 292. QATAR AZITHROMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 293. QATAR AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 294. QATAR AZITHROMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 295. QATAR AZITHROMYCIN MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 296. QATAR AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, 2018-2030 (USD MILLION)
TABLE 297. QATAR AZITHROMYCIN MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 298. RUSSIA AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 299. RUSSIA AZITHROMYCIN MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 300. RUSSIA AZITHROMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 301. RUSSIA AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 302. RUSSIA AZITHROMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 303. RUSSIA AZITHROMYCIN MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 304. RUSSIA AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, 2018-2030 (USD MILLION)
TABLE 305. RUSSIA AZITHROMYCIN MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 306. SAUDI ARABIA AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA AZITHROMYCIN MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 308. SAUDI ARABIA AZITHROMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 310. SAUDI ARABIA AZITHROMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA AZITHROMYCIN MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 312. SAUDI ARABIA AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, 2018-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA AZITHROMYCIN MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 314. SOUTH AFRICA AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA AZITHROMYCIN MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 316. SOUTH AFRICA AZITHROMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 318. SOUTH AFRICA AZITHROMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA AZITHROMYCIN MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 320. SOUTH AFRICA AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, 2018-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA AZITHROMYCIN MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 322. SPAIN AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 323. SPAIN AZITHROMYCIN MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 324. SPAIN AZITHROMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 325. SPAIN AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 326. SPAIN AZITHROMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 327. SPAIN AZITHROMYCIN MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 328. SPAIN AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, 2018-2030 (USD MILLION)
TABLE 329. SPAIN AZITHROMYCIN MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 330. SWEDEN AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 331. SWEDEN AZITHROMYCIN MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 332. SWEDEN AZITHROMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 333. SWEDEN AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 334. SWEDEN AZITHROMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 335. SWEDEN AZITHROMYCIN MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 336. SWEDEN AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, 2018-2030 (USD MILLION)
TABLE 337. SWEDEN AZITHROMYCIN MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 338. SWITZERLAND AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 339. SWITZERLAND AZITHROMYCIN MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 340. SWITZERLAND AZITHROMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 341. SWITZERLAND AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 342. SWITZERLAND AZITHROMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 343. SWITZERLAND AZITHROMYCIN MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 344. SWITZERLAND AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, 2018-2030 (USD MILLION)
TABLE 345. SWITZERLAND AZITHROMYCIN MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 346. TURKEY AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 347. TURKEY AZITHROMYCIN MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 348. TURKEY AZITHROMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 349. TURKEY AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 350. TURKEY AZITHROMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 351. TURKEY AZITHROMYCIN MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 352. TURKEY AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, 2018-2030 (USD MILLION)
TABLE 353. TURKEY AZITHROMYCIN MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 354. UNITED ARAB EMIRATES AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 355. UNITED ARAB EMIRATES AZITHROMYCIN MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 356. UNITED ARAB EMIRATES AZITHROMYCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 357. UNITED ARAB EMIRATES AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 358. UNITED ARAB EMIRATES AZITHROMYCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 359. UNITED ARAB EMIRATES AZITHROMYCIN MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 360. UNITED ARAB EMIRATES AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, 2018-2030 (USD MILLION)
TABLE 361. UNITED ARAB EMIRATES AZITHROMYCIN MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 362. UNITED KINGDOM AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 363. UNITED KINGDOM AZITHROMYCIN MARKET SIZE, BY TABLET, 2018-2030

Companies Mentioned

The leading players in the Azithromycin market, which are profiled in this report, include:
  • AbbVie
  • Amgen
  • AstraZeneca
  • Aurobindo Pharma
  • Bayer
  • Bristol-Myers Squibb
  • Cipla
  • Dr. Reddy's Laboratories
  • Eli Lilly and Company
  • Gilead Sciences
  • GlaxoSmithKline
  • Johnson & Johnson
  • Merck & Co.
  • Mylan
  • Novartis
  • Pfizer
  • Sandoz
  • Sanofi
  • Sun Pharmaceutical
  • Teva Pharmaceuticals

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages193
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 7.4 Billion
Forecasted Market Value ( USD ) by 2030 $ 10.33 Billion
Compound Annual Growth Rate5.6%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Azithromycin Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Azithromycin Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 113 Pages
  • Global
From
Azithromycin (CAS 83905-01-5) Global Market Research Report 2024 - Product Image

Azithromycin (CAS 83905-01-5) Global Market Research Report 2024

  • Report
  • 50 Pages
  • Global
From
Macrolide Antibiotics Global Market Report 2024 - Product Image

Macrolide Antibiotics Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Nontuberculous Mycobacterial Infections Market 2024-2028 - Product Image

Nontuberculous Mycobacterial Infections Market 2024-2028

  • Report
  • 177 Pages
  • Global
From
Chlamydia Market by Drug Type, Forms of Medication, Distribution Channel - Global Forecast 2025-2030 - Product Image

Chlamydia Market by Drug Type, Forms of Medication, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From

About the Azithromycin Market

Azithromycin is an antibiotic used to treat a wide range of bacterial infections. It is a macrolide-type antibiotic, which works by stopping the growth of bacteria. Azithromycin is commonly used to treat respiratory infections, skin infections, ear infections, and sexually transmitted diseases. It is also used to prevent certain bacterial infections in people with weakened immune systems. Azithromycin is available in both oral and intravenous forms, and is often prescribed in combination with other antibiotics. Azithromycin is one of the most widely prescribed antibiotics in the world. It is generally well-tolerated and has a low risk of side effects. It is also relatively inexpensive, making it an attractive option for many patients. The azithromycin market is highly competitive, with many companies offering generic versions of the drug. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.